Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10
Share news, reports & tips
27 August 2021 12:32
(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's...
6 August 2021 07:22
(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and...
8 June 2021 13:54
(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.
30 April 2021 07:38
(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.
21 April 2021 07:30
(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and...
31 March 2021 13:40
(Sharecast News) - Hikma: Jefferies upgrades to buy with a target price of 2,870p.
31 March 2021 11:56
(Sharecast News) - Analysts at Jefferies upgraded drugmaker Hikma Pharmaceuticals from 'hold' to 'buy' on Wednesday, stating the group's share price was yet to reflect "a series...
26 March 2021 13:40
(Sharecast News) - Ocado Group: Berenberg downgrades to hold with a target price of 2,390p.
11 March 2021 13:50
(Sharecast News) - Talks between Hikma Pharmaceutical and drugs giant GlaxoSmithKline have ended, the generics group confirmed on Thursday.
1 February 2021 13:44
(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.
26 January 2021 08:42
(Sharecast News) - Drugmaker Hikma Pharmaceuticals said on Tuesday that it has entered into a non-binding term sheet with GlaxoSmithKline to acquire certain parts of latter's assets in Egypt and Tunisia.
15 January 2021 16:26
(Sharecast News) - Hikma Pharmaceuticals said on Friday that it had temporarily paused the launch of its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.